891 
in addition to other amounts otherwise available for such 
purposes. 
‘‘(h) DEFINITIONS.—In this section: 
‘‘(1) AIDS.—The term ‘AIDS’ means acquired 
immune deficiency syndrome. 
‘‘(2) HIV.—The term ‘HIV’ means the human 
immunodeficiency virus, the pathogen that causes 
AIDS. 
‘‘(3) 
HIV/AIDS.—The 
term 
‘HIV/AIDS’ 
means, with respect to an individual, an individual 
who is infected with HIV or living with AIDS. 
‘‘(4) RELEVANT
EXECUTIVE
BRANCH
AGEN-
CIES.—The term ‘relevant executive branch agencies’ 
means the Department of State, the United States 
Agency for International Development, the Depart-
ment of Health and Human Services (including its 
agencies and offices), and any other department or 
agency of the United States that participates in 
international HIV/AIDS activities pursuant to the 
authorities of such department or agency or this 
Act.’’. 
(b) ASSISTANCE TO COMBAT TUBERCULOSIS.—Sub-
title A of title III of the United States Leadership Against 
HIV/AIDS, Tuberculosis and Malaria Act of 2003 (22 
U.S.C. 7631 et seq.) is amended— 
VerDate Mar 15 2010 
00:27 Dec 18, 2012
Jkt 029200
PO 00000
Frm 00891
Fmt 6652
Sfmt 6201
E:\BILLS\H6644.IH
H6644
tjames on DSK6SPTVN1PROD with
892 
(1) by redesignating section 302 as section 
302A; 
(2) in the heading of section 302A (as redesig-
nated), by inserting ‘‘OTHER PROVISIONS RELAT-
ING TO’’ before ‘‘ASSISTANCE’’; and 
(3) by inserting before section 302A (as redes-
ignated) the following new section: 
‘‘SEC. 302. ASSISTANCE TO COMBAT TUBERCULOSIS. 
‘‘(a) FINDINGS.—Congress makes the following find-
ings: 
‘‘(1) Congress recognizes the growing inter-
national problem of tuberculosis and the impact its 
continued existence has on those countries that had 
previously largely controlled the disease. 
‘‘(2) Congress further recognizes that the 
means exist to control and treat tuberculosis 
through expanded use of the DOTS (Directly Ob-
served Treatment Short-course) treatment strategy, 
including DOTS–Plus to address multi-drug resist-
ant tuberculosis, and adequate investment in newly 
created mechanisms to increase access to treatment, 
including the Global Tuberculosis Drug Facility es-
tablished in 2001 pursuant to the Amsterdam Dec-
laration to Stop TB and the Global Alliance for TB 
Drug Development. 
VerDate Mar 15 2010 
00:27 Dec 18, 2012
Jkt 029200
PO 00000
Frm 00892
Fmt 6652
Sfmt 6201
E:\BILLS\H6644.IH
H6644
tjames on DSK6SPTVN1PROD with
893 
‘‘(b) POLICY.—It is a major objective of the foreign 
assistance program of the United States to control tuber-
culosis. In all countries in which the Government of the 
United States has established development programs, par-
ticularly in countries with the highest burden of tuber-
culosis and other countries with high rates of tuberculosis, 
the United States should support the objectives of the 
Global Plan to Stop TB, including through achievement 
of the following goals: 
‘‘(1) Reduce by half the tuberculosis death and 
disease burden from the 1990 baseline. 
‘‘(2) Sustain or exceed the detection of at least 
70 percent of sputum smear-positive cases of tuber-
culosis and the successful treatment of at least 85 
percent of the cases detected in countries with estab-
lished United States Agency for International Devel-
opment tuberculosis programs. 
‘‘(3) In support of the Global Plan to Stop TB, 
the President shall establish a comprehensive, 5-year 
United States strategy to expand and improve 
United States efforts to combat tuberculosis glob-
ally, including a plan to support— 
‘‘(A) the successful treatment of 4,500,000 
new sputum smear tuberculosis patients under 
DOTS programs by 2013, primarily through di-
VerDate Mar 15 2010 
00:27 Dec 18, 2012
Jkt 029200
PO 00000
Frm 00893
Fmt 6652
Sfmt 6201
E:\BILLS\H6644.IH
H6644
tjames on DSK6SPTVN1PROD with
894 
rect support for needed services, commodities, 
health workers, and training, and additional 
treatment through coordinated multilateral ef-
forts; and 
‘‘(B) the diagnosis and treatment of 
90,000 new multiple drug resistant tuberculosis 
cases by 2013, and additional treatment 
through coordinated multilateral efforts. 
‘‘(c) AUTHORIZATION.—To carry out this section and 
consistent with section 1321 of the Global Partnerships 
Act of 2012, the President is authorized to furnish assist-
ance, on such terms and conditions as the President may 
determine, for the prevention, treatment, control, and 
elimination of tuberculosis. 
‘‘(d) COORDINATION.—In carrying out this section, 
the President shall coordinate with the World Health Or-
ganization, the Global Fund to Fight AIDS, Tuberculosis, 
and Malaria, and other organizations with respect to the 
development and implementation of a comprehensive tu-
berculosis control program. 
‘‘(e) PRIORITY TO STOP TB STRATEGY.—In fur-
nishing assistance under subsection (c), the President 
shall give priority to— 
‘‘(1) direct services described in the Stop TB 
Strategy, including expansion and enhancement of 
VerDate Mar 15 2010 
00:27 Dec 18, 2012
Jkt 029200
PO 00000
Frm 00894
Fmt 6652
Sfmt 6201
E:\BILLS\H6644.IH
H6644
tjames on DSK6SPTVN1PROD with
895 
Directly Observed Treatment Short-course (DOTS) 
coverage, rapid testing, treatment for individuals in-
fected with both tuberculosis and HIV, and treat-
ment for individuals with multi-drug resistant tuber-
culosis (MDR–TB), strengthening of health systems, 
use of the International Standards for Tuberculosis 
Care by all providers, empowering individuals with 
tuberculosis, and enabling and promoting research to 
develop new diagnostics, drugs, and vaccines, and 
program-based operational research relating to tu-
berculosis; and 
‘‘(2) funding for the Global Tuberculosis Drug 
Facility, the Stop Tuberculosis Partnership, and the 
Global Alliance for TB Drug Development. 
‘‘(f) ASSISTANCE FOR THE WORLD HEALTH ORGANI-
ZATION AND THE STOP TUBERCULOSIS PARTNERSHIP.— 
In carrying out this section, the President, acting through 
the Administrator of the United States Agency for Inter-
national Development, is authorized to provide increased 
resources to the World Health Organization and the Stop 
Tuberculosis Partnership to improve the capacity of coun-
tries with high rates of tuberculosis and other affected 
countries to implement the Stop TB Strategy and specific 
strategies related to addressing multiple drug resistant tu-
VerDate Mar 15 2010 
00:27 Dec 18, 2012
Jkt 029200
PO 00000
Frm 00895
Fmt 6652
Sfmt 6201
E:\BILLS\H6644.IH
H6644
tjames on DSK6SPTVN1PROD with